Jigar Raythatha - Constellation Pharmaceuticals President CEO, Director
CEO
Mr. Jigar Raythatha severs as President and Chief Executive Officer, Director of the company since March 2017 since 2017.
| Age | 40 |
| Tenure | 7 years |
| Professional Marks | MBA |
| Phone | 617 714-0555 |
| Web | www.constellationpharma.com |
Constellation Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (22.41) % which means that it has lost $22.41 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (40.7) %, meaning that it created substantial loss on money invested by shareholders. Constellation Pharmaceuticals' management efficiency ratios could be used to measure how well Constellation Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 3.37 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Constellation Pharmaceuticals has a current ratio of 15.08, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Constellation Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Constellation Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Constellation Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Constellation to invest in growth at high rates of return. When we think about Constellation Pharmaceuticals' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 3 records | CEO Age | ||
| Naeem Ghauri | NetSol Technologies | 67 | |
| Matthew Flake | Q2 Holdings | 52 | |
| David Fox | Q2 Holdings | 45 | |
Management Performance
| Return On Equity | -40.7 | |||
| Return On Asset | -22.41 |
Constellation Pharmaceuticals Leadership Team
Elected by the shareholders, the Constellation Pharmaceuticals' board of directors comprises two types of representatives: Constellation Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Constellation. The board's role is to monitor Constellation Pharmaceuticals' management team and ensure that shareholders' interests are well served. Constellation Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Constellation Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Emma Reeve, CFO, Senior Vice President | ||
| Brenda Sousa, Vice President - Human Resources | ||
| Matthias Jaffe, CFO | ||
| Brad Prosek, Senior Vice President Corporate Development | ||
| Jessica Christo, Chief Product Development Officer | ||
| Elizabeth Trehu, Independent Director | ||
| Robert Tepper, Independent Director | ||
| Anthony Evnin, Independent Director | ||
| Mark Goldsmith, Executive Chairman , Venture Partner | ||
| Keith Dionne, President CEO, Director | ||
| Steven Hoerter, Independent Director | ||
| Peter Svennilson, Independent Director | ||
| James Audia, Chief Scientific Officer | ||
| Scott Braunstein, Independent Director | ||
| Ronald Aldridge, IR Contact Officer | ||
| Jigar Raythatha, President CEO, Director | ||
| Adrian Senderowicz, Senior Vice President and Chief Medical Officer | ||
| Patrick Trojer, Senior Vice President EZH2, Franchise and Head of Translational Sciences | ||
| Michael Cooper, Chief Medical Officer | ||
| Robert Sims, Senior Vice President of Research |
Constellation Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Constellation Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -40.7 | |||
| Return On Asset | -22.41 | |||
| Current Valuation | 1.24 B | |||
| Shares Outstanding | 47.97 M | |||
| Shares Owned By Insiders | 1.53 % | |||
| Shares Owned By Institutions | 98.47 % | |||
| Number Of Shares Shorted | 3.52 M | |||
| Price To Earning | (0.72) X | |||
| Price To Book | 4.32 X | |||
| Gross Profit | (28.37 M) |
Pair Trading with Constellation Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Constellation Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Constellation Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to International Game could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace International Game when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back International Game - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling International Game Technology to buy it.
The correlation of International Game is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as International Game moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if International Game moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for International Game can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Constellation Stock
If you are still planning to invest in Constellation Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Constellation Pharmaceuticals' history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |